Macrophage Pharma Limited
Trending Articles
Related Content
Media
Immuno-oncology CRO secures Macrophage Pharma agreement
Aquila BioMedical, an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma to support its preclinical immuno-oncology programmes